3//SEC Filing
Bellevue Global Life Science Investors LLC 3
Accession 0000899243-23-004424
CIK 0001840425other
Filed
Feb 8, 7:00 PM ET
Accepted
Feb 9, 4:49 PM ET
Size
5.0 KB
Accession
0000899243-23-004424
Insider Transaction Report
Form 3
Holdings
- 1,725,000
Common Stock
Footnotes (3)
- [F1]This Form 3 is being filed by Bellevue Global Life Sciences Investors LLC, the sponsor of the Issuer (the "Sponsor"). Kuk Hyoun Hwang, the Issuer's chief executive officer and director, is the founder and managing partner of Bellevue Capital Management LLC ("Bellevue Capital"), the general partner of our sponsor, and has voting and dispositive power over the shares.
- [F2]Includes up to 225,000 shares subject to forfeiture depending on the extent to which the underwriter's over allotment is exercised, if at all.
- [F3]Includes 680,000 shares of common stock held by the Sponsor which, pursuant to a convertible promissory note in the principal amount of $3,400,000 between the Sponsor and BCM Europe AG, a wholly-owned subsidiary of Bellevue Capital, the Sponsor, at its election or the election of BCM Europe AG on or after the initial public offering the common stock, can transfer the 680,000 shares to BCM Europe AG in satisfaction of the note.
Documents
Issuer
Bellevue Life Sciences Acquisition Corp.
CIK 0001840425
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001953768
Filing Metadata
- Form type
- 3
- Filed
- Feb 8, 7:00 PM ET
- Accepted
- Feb 9, 4:49 PM ET
- Size
- 5.0 KB